Bert O’Malley of the Perelman School of Medicine comments on using a miniature robotic arm to assist in minimally invasive surgeries.
Perelman School of Medicine
Mahendra Bhati of the Perelman School of Medicine is mentioned for leading the Penn field trial of the DSM-5.
Winners of Penn’s MyHeartMap Challenge, led by Raina Merchant of the Perelman School of Medicine, are featured.
NSAIDs and Cardiovascular Risk Explained, According to Studies From Penn's Perelman School of Medicine
After nearly 13 years of study and intense debate, a pair of new papers from the Perelman School of Medicine, at the University of Pennsylvania have confirmed exactly how a once-popular class of anti-inflammatory drugs leads to cardiovascular risk for people taking it.
Genetically Modified T Cell Therapy Shown to Be Safe, Lasting in Penn Medicine Study of HIV Patients
HIV patients treated with genetically modified T cells remain healthy up to 11 years after initial therapy, researchers from the Perelman School of Medicine at the University of Pennsylvania report in the new issue of Science Translational Medicine. The results provide a framework for the use of this type of gene therapy as a powerful weapon in the treatment of HIV, cancer, and a wide variety of other diseases.
Arthur Caplan of the Perelman School of Medicine discusses how Facebook can be compared to a will.
Kevin Volpp of the Perelman School of Medicine and the Wharton School says, “There’s not a lot of peer-reviewed evidence that achieves sustained improvements in health behavior and health outcomes.”